Cargando…
Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma
BACKGROUND: Endoglin (CD105) has been considered a prognostic marker for hepatocellular carcinoma (HCC), and widely used as an appropriate targeting for antiangenesis therapy in some cancers. Our aim was to evaluate the distribution and expression of CD105 in the liver of patients with HCC, and to d...
Autores principales: | Yu, Decai, Zhuang, Linyuan, Sun, Xitai, Chen, Jun, Yao, Yongzhong, Meng, Kui, Ding, Yitao |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1941740/ https://www.ncbi.nlm.nih.gov/pubmed/17608955 http://dx.doi.org/10.1186/1471-2407-7-122 |
Ejemplares similares
-
Expression of endoglin (CD105) in cervical cancer
por: Zijlmans, H J, et al.
Publicado: (2009) -
Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
por: Kasprzak, Aldona, et al.
Publicado: (2018) -
Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
por: Di Paolo, Virginia, et al.
Publicado: (2018) -
CD105 (Endoglin) as negative prognostic factor in AML
por: Kauer, Joseph, et al.
Publicado: (2019) -
Identification of CD105 (endoglin) as novel risk marker in CLL
por: Greiner, Sarah M., et al.
Publicado: (2022)